Table 1 Characteristics of the NLPHL patients included in this study.
Case | Gender | Age (year) | Disease status | Localization | LP cells IgD+ | Reactivity against M. cat. RpoC | Reactivity against M. osl. Succinate-CoA ligase sub α | HLA-DRB1*04 or HLA-DRB1*07 |
|---|---|---|---|---|---|---|---|---|
1 | m | 52 | Relapse | Axillary | No | No | No | No |
2 | m | 15 | Relapse | Supraclavicular | No | No | No | No |
3 | m | 14 | 2nd relapse | Cervical | Yes | yes | No | Yes |
4 | m | 65 | First manifestation | Cervical | No | No | No | Yes |
5 | f | 37 | First manifestation | Retroperitoneal | No | No | No | No |
6 | m | 15 | Relapse | Cervical | Yes | Yes | No | Yes |
7a | m | 51 | 2nd relapse | Axillary | No | No | No | No |
7b | m | 51 | 2nd relapse | Axillary | No | No | No | No |
8a | m | 40 | Primary progressive | Abdominal | No | No | No | No |
8b | m | 40 | Primary progressive | Abdominal | No | No | No | No |
9 | m | 42 | Relapse | Inguinal | Yes | Yes | No | Yes |
10 | m | 12 | 2nd relapse | Inguinal | Yes | Yes | No | Yes |
11 | m | 15 | First manifestation | Cervical | Yes | No | Yes | Yes |
12 | m | 31 | First manifestation | Cervical | No | No | No | Yes |
13 | m | 18 | First manifestation | Cervical | Yes | Yes | No | Yes |
14 | m | 30 | First manifestation | Parotid | Yes | Yes | No | Yes |
15 | f | 16 | First manifestation | Axillary | Yes | No | No | No |
